GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

CeCors CEOS · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

+0.10%

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

—

FY2015FY2025

Net income

$3.1m

FY2015FY2025

Free cash flow

$1.0m

FY2015FY2025

Shareholders' equity

$1.9m

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Revenue—$6.3m$419,299$19,316——$1,543$1,543$1.5m$3.9m
Operating income−$2.0m−$320,168−$797,504−$355,790−$331,660−$4,340−$730−$662−$632,000−$1.4m
Net income$3.1m−$350,578−$1.3m−$497,760−$343,699−$4,360−$696−$632−$602,000−$1.7m
Diluted earnings per share0.01-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.06-0.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Total assets$3.7m$4.1m$1.7m$574,965$626,705$209,337$209,337$130,863$995,000$1.2m
Cash and short-term investments$545,851$2.3m$376,007$3,435$71,251$0$0—−$1,000−$35,648
Total liabilities$1.8m$5.1m$2.5m$1.4m$988,489$4,790$4,790$4,565$4.5m$4.1m
Debt—$1.2m$1.0m$1.3m$509,846$3,933$3,933$3,933$3.9m$3.5m
Shareholders' equity$1.9m−$1.0m−$747,411−$814,089−$361,784$204,547$204,547$126,298−$3.5m−$2.9m
Shares outstanding332m332m332m332m500m210m210m65m10m—

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Cash from operations$1.0m$2.1m$159,759−$92,891−$92,312−$4,360−$602−$763−$733,000−$1.8m
Capital spending−$3−$78,655−$159,759————−$3—−$9,838
Free cash flow$1.0m$2.0m—−$92,891−$92,312−$4,360−$602−$766−$733,000−$1.8m

Latest quarters

By quarter end

Mar 2026Mar 2025Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023
Revenue——$1.3m$685,686$238,076$117,227$58,266$5,730
Operating income−$292,483−$704,708−$77,874−$208,374−$254,987−$259,900−$172,110−$110,510
Net income−$409,901−$524,689−$84,140−$217,827−$763,776−$265,938−$178,266−$115,971
Diluted earnings per share-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$3.2m—$2.7m$2.0m$1.7m$2.0m$1.9m$569,796
Cash and short-term investments$2.6m—$1.1m$574,755$376,007$93,907$70,231$6,959
Debt——$370,860$254,384$385,600$991,906$865,848$767,416
Shareholders' equity$1.5m—−$1.0m−$951,076−$747,411−$14,486$222,232−$899,302

Growth per year

Compound annual rate

3 years5 years10 years
Operating income76.6%—3.4%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017
Price to earnings0.2-1.6-0.3-0.4-2.9-4.4-128.0-10.7
Price to sales—0.11.010.1——57.74.4

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return51%21%65%-72%416%198%-80%567%1575%608%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.